| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Common Stock | 19.6k | $0.00 | $0 | | 06/15/2023 |
| 06/15/2023 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to buy) | 27.4k | $2.47 | $67.6k | | 06/15/2023 |
| 06/07/2023 | Xeris Biopharma Holdings, Inc. | | Grant | Common Stock | 42.5k | $0.00 | $0 | | 06/07/2023 |
| 05/31/2023 | Design Therapeutics, Inc. | DSGN | Grant | Stock Option (right to buy) | 15k | $5.63 | $84.4k | | 05/31/2023 |
| 01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
| 01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
| 06/16/2022 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 28.5k | $2.01 | $57.3k | | 06/16/2022 |
| 06/16/2022 | Poseida Therapeutics, Inc. | PSTX | Grant | Common Stock | 19.6k | $0.00 | $0 | | 06/16/2022 |
| 06/15/2022 | Design Therapeutics, Inc. | DSGN | Grant | Stock Option (right to buy) | 15k | $13.69 | $205.4k | | 06/15/2022 |
| 06/08/2022 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 25k | $2.10 | $52.5k | | 06/08/2022 |
| 06/08/2022 | Xeris Biopharma Holdings, Inc. | | Grant | Common Stock | 15k | $0.00 | $0 | | 06/08/2022 |
| 02/10/2022 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 9.2k | $30.44 | $280k | | 02/10/2022 |
| 10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 25.2k | $12.50 | $315.2k | | 10/05/2021 |
| 10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 20k | $10.00 | $200k | | 10/05/2021 |
| 10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 11.2k | $4.68 | $52.5k | | 10/05/2021 |
| 10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Stock Option (Right to Buy) | 11.2k | $3.90 | $43.8k | | 10/05/2021 |
| 10/05/2021 | XERIS PHARMACEUTICALS INC | XERS | Disposition | Common Stock | 5.7k | $0.00 | $0 | | 10/05/2021 |
| 10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 11.2k | $4.68 | $52.5k | | 10/05/2021 |
| 10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 11.2k | $3.90 | $43.8k | | 10/05/2021 |
| 10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 20k | $10.00 | $200k | | 10/05/2021 |
| 10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 25.2k | $12.50 | $315.2k | | 10/05/2021 |
| 10/05/2021 | Xeris Biopharma Holdings, Inc. | | Grant | Common Stock | 5.7k | $0.00 | $0 | | 10/05/2021 |
| 07/23/2021 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 25.8k | $8.63 | $222.9k | | 07/23/2021 |
| 06/16/2021 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 20k | $8.98 | $179.6k | | 06/16/2021 |
| 06/08/2021 | XERIS PHARMACEUTICALS INC | XERS | Grant | Stock Option (Right to Buy) | 11.2k | $3.90 | $43.8k | | 06/08/2021 |
| 03/25/2021 | Design Therapeutics, Inc. | DSGN | Grant | Stock Option (right to buy) | 15k | $20.00 | $300k | | 03/25/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Common Stock | 23.5k | $0.00 | $0 | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 12.5k | $10.73 | $134.1k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 14.8k | $9.63 | $142.3k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 18.3k | $7.65 | $140.2k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 22.8k | $6.05 | $137.7k | | 03/19/2021 |
| 03/19/2021 | Neos Therapeutics, Inc. | NEOS | Disposition | Stock Option (Right to Buy) | 46.9k | $1.44 | $67.5k | | 03/19/2021 |
| 02/10/2021 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 11k | $29.70 | $326.7k | | 02/10/2021 |
| 07/09/2020 | Poseida Therapeutics, Inc. | PSTX | Grant | Stock Option (Right to Buy) | 20k | $16.00 | $320k | | 07/09/2020 |
| 06/10/2020 | Neos Therapeutics, Inc. | NEOS | Grant | | 23.5k | $0.00 | $0 | | 06/10/2020 |
|